U.S. Court of Appeals sides with drugmakers on rebate program

Drugmakers can limit deliveries to hospitals and clinics of discounted drugs under federal program, courts rule loss to hospitals


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button